Recently, we have shown that the transplantation of spinal-cord-derived neural stem/progenitor cells (NSPCs) can contribute to the repair of injured spinal cords in adult rats, which may correspond to a behavioral recovery. To apply these results to clinical practice, a system for supplying human NSPCs on a large scale must be established. However, human spinal-cord-derived NSPCs are known to have a low proliferation rate, compared with forebrain-derived NSPCs. This low proliferative potency limits the feasibility of large-scale spinal cord-derived NSPC use. Thus, forebrain-derived NSPCs should be examined as an alternative to spinal-cordderived NSPCs for the treatment of spinal cord injuries. In this study, we compared spinal-cord-and forebrainderived NSPCs transplanted into injured spinal cords with respect to their fates in vivo as well as the animals' functional recovery. Both spinal-cord-and forebrainderived NSPCs promoted functional recovery in rats with spinal cord injuries. While both spinal-cord-and forebrain-derived NSPCs survived, migrated and differentiated into neurons, astrocytes and oligodendrocytes in response to the microenvironment within the injured spinal cord after transplantation, forebrain-derived NSPCs differentiated into more neurons and fewer oligodendrocytes, compared to spinal-cord-derived NSPCs. Neurons that had differentiated from the transplanted forebrainderived NSPCs were shown to be positive for neurotransmitters like GABA, glutamate and glycine, although authentic glycinergic neurons are not normally present within the forebrain. Thus, at least a subpopulation of the transplanted forebrain-derived NSPCs differentiated into spinal-cord-type neurons. In conclusion, forebrain-derived NSPCs could be used as an alternative to spinalcord-derived NSPCs as a potential therapeutic agent for spinal cord injuries.
Introduction
Since the adult central nervous system (CNS) has little potential for regeneration, spinal cord injury (SCI) usually results in severe damage leading to paraplegia, tetraplegia or worse. Many strategies have been used in attempts to develop new therapies that will allow patients to regain the use of their paralyzed limbs. Experiments on neural transplantation for SCI started in 1981 with peripheral nerve transplantation [David and Aguayo, 1981; Richardson and Issa, 1984] . In 1993, Bregman and her colleagues reported the transplantation of fetal spinal cord into immature and adult rats with SCI Bernstein-Goral and Bregman, 1993 ; reviewed by Olson and Cheng, 1997] . In their report, the transplants survived and integrated within the host tissue, which may have resulted in functional improvement. Although fetal spinal cord transplantation could be a scientifically promising way of treating SCI, the associated problems include a lack of donors and, most importantly, the requirement of large amounts of fetal tissues; this last factor has caused ethical argument regarding such a procedure.
On the other hand, recent progress in stem cell biology has made it possible to isolate or expand neural stem/progenitor cells (NSPCs) from both embryonic and adult brain and spinal cord [Brustle et al., 1998; Davis and Temple, 1994; Flax et al., 1998; Gritti et al., 1996; Johe et al., 1996; Kalyani et al., 1997; Kanemura et al., 2002; Keyoung et al., 2001; Kukekov et al., 1999; Palmer et al., 1997; Quinn et al., 1999; Roy et al., 2000; Svendsen et al., 1999; Weiss et al., 1996 ; reviewed by Okano, 2002a, b] . These cells can be expanded through multiple passages in vitro in the presence of appropriate mitogens, like fibroblast growth factor 2 (FGF-2), epidermal growth factor (EGF) or both, to produce a large number of cells for transplantation from a small amount of fetal CNS tissue in vitro, these floating cell aggregates are called neurospheres . Therefore, the expansion of NSPCs in vitro may overcome the practical and ethical problems associated with fetal tissue transplantation, providing a potential source for the graft material required for attempts to regenerate injured spinal cord. Recently, we have shown that the transplantation of fetal spinal-cord-derived NSPCs (neurosphere cells) can contribute to the repair of injured spinal cord in adult rats when transplanted at an appropriate time point [Ogawa et al., 2002 ; reviewed by Okano, 2002a, b and Okano et al., 2003] . Grafted NSPCs differentiated into neurons, astrocytes and oligodendrocytes in response to the microenvironment within the injured spinal cord, which might have enabled a functional recovery. To apply these basic experimental results to clinical practice, a system for supplying human NSPCs on a large scale must be established. However, human spinal-cord-derived NSPCs have a low proliferation rate (doubling time, 223.4 B 31.6 h) [Y.K. and H.O., unpubl . observations], compared with forebrain-derived NSPCs (doubling time, 94.2 B 19.4 h) [Kanemura et al., 2002] . A similar conclusion is also reported from another group [Jain et al., 2003] . This low proliferative potency of spinal-cord-derived NSPCs limits the feasibility of large-scale cell therapy. Thus, forebrain-derived NSPCs should be examined as an alternative to spinal-cord-derived NSPCs as a source of cell therapy for spinal cord injuries. In this study, we compared spinal-cord-and forebrain-derived NSPCs transplanted into injured spinal cord with respect to their fates in vivo and the animals' functional recovery.
Materials and Methods
All surgical interventions and animal care procedures were in accordance with the Laboratory Animal Welfare Act, the Guide for the Care and Use of Laboratory Animals (National Institutes of Health) and the Guidelines and Policies for Animal Surgery provided by the Animal Study Committee of the Central Institute for Experimental Animals and of Keio University and were approved by the ethics committee of Keio University.
Cell Preparation
The method for the culture and expansion of NSPCs has been previously described by . In brief, the striatum and spinal cord of enhanced green fluorescent protein (GFP) transgenic rats (Sprague-Dawley rats: a gift from Dr. Masaru Okabe, Osaka University, Japan) were dissected using a sterile technique on embryonic day 14. Embryonic day 1 was defined as the day of conception, established by the presence of a vaginal plug. Each tissue was dissociated by mechanical trituration in the culture medium using a sterile, fire-polished glass Pasteur pipette. Each cell type was then collected by centrifugation and resuspended in separate culture mediums. The culture medium consists of DMEM/F 12 supplemented with the hormone mixture used by ; human recombinant FGF-2 (20 ng/ml; Prepro Tech Inc., Rocky Hill, N.J., USA) and human recombinant EGF (20 ng/ ml; Prepro Tech Inc.) were added every 2 days. Passages were performed once every 6-7 days for the spinal-cord-derived neurospheres and every 4-5 days for the forebrain-derived neurospheres. After the third passage, both types of NSPCs were used in the subsequent experiments.
Differentiation Assay
To examine the phenotype of the NSPCs before and after their differentiation in vitro, the neurospheres were plated on polyornithine-coated glass coverslips and cultured in the same medium without FGF-2 and EGF. After 5 days in vitro, the cells were fixed with 4% paraformaldehyde for 15 min and incubated overnight using the following primary antibodies: anti-GFP (rabbit polyclonal, 1:400, MBL, Japan; mouse monoclonal, 1:400, Molecular Probes, Eugene, Oreg., USA), anti-human Nestin (mouse monoclonal, 1:200, Chemicon, Temecula, Calif., USA), anti-TuJ-1 (mouse monoclonal, 1:500, BAbCO, Richmond, Calif., USA), anti-2)3)-cyclic nucleotide 3)-phosphohydrolase (CNPase, mouse monoclonal, 1:200, Sigma, St. Louis, Mo., USA), anti-APC (mouse monoclonal, 1:100, Oncogene, San Diego, Calif., USA), anti-GFAP (rabbit polyclonal, 1:600, Dako, Glostrup, Denmark), anti-GABA (rabbit polyclonal, 1:500, Sigma), anti-glutamate (rabbit polyclonal, 1:100, Chemicon) and anti-glycine (rabbit polyclonal, 1:100, Chemicon). The primary antibodies were diluted in phosphate-buffered saline (PBS) containing 5% normal goat serum and 0.01% Triton X-100. After 3 washes, the cells were incubated with the appropriate secondary antibodies (Alexa Fluor ® 568, 488 anti-rabbit IgG, 1:800; 568, 488 anti-mouse IgG, 1:800; 568 anti-human IgG, 1:800, Molecular Probes) at room temperature for 1 h. The secondary antibodies were also diluted in PBS containing 5% normal goat serum and 0.01% Triton X-100. The quantification of the differentiated phenotypes was accomplished by counting the immunopositive cells on each coverslip. For each condition, 3 coverslips were evaluated, and 3 fields were randomly captured using a confocal scanning laser microscope (LSM510, Carl Zeiss, Jena, Germany) at a magnification of !200. The number of nuclei was counted using Hoechst staining, and the numbers of Nestin, TuJ-1, CNPase and GFAP-immunopositive cells in each field were determined. These numbers were summed to give a total representative count for each coverslip, and the percentages of each phenotype were calculated.
Spinal Cord Injury Model
Adult (230-250 g) female Sprague-Dawley rats (Japan Crea Inc., Tokyo) were used for all the experimental groups. Spinal contusion lesions were made in accordance with the MASCIS method using an NYU impactor [Gruner, 1992; Jakeman et al., 2000; Kuhn and Wrathall, 1998; Widenfalk et al., 2003 ]. Briefly, a laminectomy was performed at the thoracic (Th) 10 level under a dissecting microscope, and the spinal cord was contused by dropping a 10-gram weight on the dura from a height of 25 mm. The tip of the weight had a diameter of 2.5 mm. The Th 8 and Th 11 spinous processes were immobilized to minimize the movement of the thoracic spine during the contusion. The rat's body temperature was kept at 37°C throughout the operation.
Transplantation
Transplantation of the neurospheres derived from the forebrain or spinal cord was performed 9 days after the SCI (forebrain-derived neurospheres, n = 20; spinal-cord-derived neurospheres, n = 18). For the transplantation, neurospheres that had undergone three passages were resuspended in the medium without FGF-2 and EGF at a cell density of approximately 1 ! 10 8 cells/ml. The number of the viable cells in the suspensions was determined by cell counting using Trypan blue dye exclusion. After the lesion site had been re-exposed, a glass micropipette attached to a Hamilton syringe was inserted into the spinal cord, and 5 Ìl of the neurosphere suspension was injected using a stereotaxic injector (KDS 310, Muromachi-kikai, Tokyo, Japan) at a rate of 1 Ìl/min into the epicenter of the injured spinal cord. Instead of the neurospheres, the culture medium without FGF-2 and EGF was injected into the cavity in the control group (vehicle transplantation and SCI, n = 10).
Immunohistochemistry
After the completion of the behavioral assessment, the animals were anesthetized and perfused transcardially with 4% paraformaldehyde for 15 min. The spinal cords were then removed and postfixed in the same fixative for an additional hour at 4°C. Tissues were transferred to 10% sucrose in PBS and immersed overnight at 4°C, then transferred to 30% sucrose and immersed overnight. The tissues were then embedded in optimal cutting temperature compound, and sagittal (30 Ìm thick) and axial (20 Ìm thick) sections were cut using a cryostat; the sections were then mounted on glass slides. The sections were incubated overnight using the following primary antibodies: anti-GFP (1:400), anti-Hu (mouse monoclonal, 1:500, donated by Dr. Robert Darnell, Rockefeller University), anti-NeuN (mouse monoclonal, 1:200, Chemicon), anti-APC (1:100), anti-GFAP (1:500), anti-neurofilament (RT97, mouse monoclonal, 1:400, Chemicon), anti-GABA (1:500), anti-glutamate (1:100) and anti-glycine (1:100). The primary antibodies were diluted in PBS containing 5% normal goat serum and 0.01% Triton X-100. After 3 washes, the sections were incubated with the appropriate secondary antibodies (Alexa Fluor ® 568, 488 anti-rabbit IgG, 1:800; 568, 488 anti-mouse IgG, 1:800; 568 anti-human IgG, 1:800, Molecular Probes) at room temperature for 1 h. The secondary antibodies were also diluted in PBS containing 5% normal goat serum and 0.01% Triton X-100.
Quantitative Analyses
For the quantitative analyses of the transplanted donor-derived cells in the spinal cord, 5 rats were analyzed in each group. Thirty-six sections (18 cranial and 18 caudal to the injury epicenter, at 300-Ìm intervals) were taken from the spinal cords that had received neurospheres derived from one of the two cell sources. The sections were immunostained with lineage-specific antibodies for each phenotype (anti-Hu for neurons, anti-APC for oligodendrocytes, anti-GFAP for astrocytes) and anti-GFP. For the quantitative analysis, images of 3 random regions were obtained for each section. All the double-positive cells (i.e. cells that were positive for both GFP and a lineagespecific antibody) and the GFP-positive cells in each field were counted using a confocal scanning laser microscope (LSM510, Zeiss) at a magnification of !200. The number of double-positive cells and GFP-positive cells in the 36 sections was summed, and the proportion of GFP-positive cells that were double-positive was calculated.
Behavioral Analysis
Functional tests were performed before the injury, before transplantation and once a week until 12 weeks after the transplantation. Locomotive activity was evaluated using the open-field walking scoring system, and locomotor ability was measured for 5 min. One animal at a time was allowed to move freely inside a circular area with a nonslip rubber floor (100 cm in diameter, wall height of 20 cm). Three independent examiners who were unaware of the treatment status observed the hindlimb movements of the rat and assessed the animal's locomotor function according to the BBB scale [Basso et al., 1996] . The mean of the values assigned by each examiner was used as the final score. The animals were also subjected to testing using the inclined-plane method [Rivlin and Tator, 1977] . In this method, the rats are placed in such a position that their body axis is perpendicular to the axis of the inclined plane. The maximum angle at which the animal could maintain a stable position on the inclined plane for 5 s was recorded.
Statistics
All of the data were presented as the mean B standard error. Statistical significance was determined using the Student t-test, with a value of p ! 0.05 considered significant.
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Results

In vitro Characterization of Fetal Spinal-Cord-and Forebrain-Derived NSPCs
To investigate the phenotype of spinal-cord-and forebrain-derived NSPCs before and after the induction of differentiation in vitro by the withdrawal of EGF and FGF-2 from the culture medium and the spreading of the neurospheres on the polyornithine-coated coverslips, neurosphere cells were immunostained with anti-Nestin, anti-TuJ-1, anti-GFAP, anti-APC and anti-CNPase. In the presence of FGF-2 and EGF, both fetal spinal-cord-and forebrainderived NSPCs proliferated and formed neurospheres; the morphologies of the neurospheres derived from the two types of NSPCs were indistinguishable. The majority of the cells included in both spinal-cord-and forebrain-derived neurospheres were nestin positive (90%), and a small portion of them expressed lineage-specific markers (data not shown). Five days after the induction of differentiation in the spinal-cord-and forebrain-derived neurospheres, the cells were immunostained once again using the various markers. Compared to the spinal-cord-derived NSPCs ( fig.  1A, B) , the forebrain-derived NSPCs ( fig. 1G, H fig. 1M ). These findings suggested that the characteristics of spinal-cord-and forebrainderived neurospheres were slightly different in terms of their phenotype pattern after differentiation in vitro, although both neurosphere types gave rise to 3 major lineages (neurons, astrocytes and oligodendrocytes) in vitro.
Survival and Migration of both Spinal-Cord-and Forebrain-Derived NSPCs in the Injured Spinal Cord after Transplantation
To characterize the differentiation capacity and therapeutic values of spinal-cord-and forebrain-derived NSPCs in vivo, we transplanted these cells into the injured spinal cord. The contusive rat spinal cord injury, induced at the level of Th 10 using an NYU impactor, created a central core lesion that was composed of scar tissue and cavities. The expanded lesion cavity completely disrupted almost all portions of the gray matter except for the peripheral rim of the white matter ( fig. 2A, B) . Twelve weeks after transplantation, cells originating from both the grafted spinal-cordand forebrain-derived NSPCs had survived and were well integrated within the host spinal cord ( fig. 2C-H) . Although the precise number of the surviving graft-derived cells within the injured spinal cord cannot be determined due to their dense aggregation, cells derived from both types of NSPCs appeared to have survived in a similar fashion, roughly judged from the area of GFP-positive cells distribution of the axial image of the spinal cord. Grafted NSPC-derived cells mainly remained in the central part of the spinal cord, with some migration into the rim surrounding the lesion, especially in the ventral region of the spinal cord ( fig. 2C-E) . Some of the grafted cells were distributed in the subpial white matter ( fig. 2G ). The majority of rostral-caudally migrating cells were observed in the white matter ( fig. 2H ). These findings suggested that both NSPC types could survive and migrate within the injured spinal cord after transplantation.
Comparison of Spinal-Cord-and Forebrain-Derived NSPC Phenotypes of Injured Spinal Cord after Transplantation
To investigate the phenotype of the cells derived from the grafted NSPCs in the injured spinal cord, the sections were immunostained with anti-Hu antibody for neurons, anti-GFAP antibody for astrocytes and anti-APC antibody for oligodendrocytes. To identify the graft-derived neuronal and oligodendrocytes in vivo, we used anti-Hu and anti-APC antibodies (instead of anti-TuJ-1 and antiCNPase), respectively, by taking advantage of their preferential immunolocalizations in cell bodies and/or nuclei. After both spinal-cord-and forebrain-derived NSPC transplantation, Hu-, GFAP-and APC-positive cells (all of which were also GFP-positive) were observed in the injured spinal cord. Hu-positive cells had bi-or tripolar neurites identical to in vitro features ( fig. 3A ) and were mainly located in the margin area of the grafted cells within the white matter of the host spinal cord ( fig. 3D) . No double-positive cells for GFP and NeuN were observed. GFAP-positive cells had multiple processes that mainly extended horizontally and radially along the rostral-caudal axis ( fig. 3B ). While most GFAP-positive cells migrated radially from the center of the spinal cord to the Watanabe/Nakamura/Iwanami/Fujita/ Kanemura/Toyama/Okano white matter ( fig. 3E ), some cells distributed in the subpial white matter ( fig. 1G ). Other GFAP-positive cells located in the central portion of the injured spinal cord had formed aggregates. APC-positive cells also had multiple processes that extended randomly in the injured spinal cord ( fig. 3C ). These cells were located randomly throughout the spinal cord ( fig. 3F ). The quantitative analysis revealed that Hu-, GFAP-and APC-positive cells accounted for 7.9 B 2.4, 53.0 B 10.1 and 39.3 B 7.4% of the GFP-positive cells, respectively, at 12 weeks after the transplantation of the spinal-cord-derived NSPCs. In contrast, Hu-, GFAP-and APC-positive cells accounted for 17.8 B 4.9, 65.5 B 12.5 and 13.9 B 3.3%, of the GFPpositive cells, respectively, at 12 weeks after the transplantation of the forebrain-derived NSPCs ( fig. 3J ). Both types of NSPCs differentiated into GABA-( fig. 3I ) and glutamate-positive neurons in vivo ( fig. 3H ). Interestingly, although the forebrain-derived NSPCs never differentiated into glycine-positive neurons in vitro, both types of NSPCs differentiated into glycine-positive neurons in vivo ( fig. 3G) . Most of the grafted NSPCs, which migrated into the white matter, were APC-positive oligodendrocytes ( fig. 4A, B) . These cells became aligned along RT97-positive neurofilaments in the spared white matter at the lesion site ( fig. 4C ) and were also in contact with the RT97-positive neurofilaments ( fig. 4D ).
Transplantation of Spinal-Cord-and Forebrain-Derived NSPCs Improved Motor Function Recovery
The motor performance of three groups (spinal-cordand forebrain-derived NSPC transplantation groups and the control group) was evaluated by BBB scoring once a week until 12 weeks after the transplantation or treatment ( fig. 5A ). Immediately after injury, all of the rats showed no movement in their hindlimbs. Nine days after the injury, almost no recovery of movement was seen in any of the rats (BBB score 0 B 0.18). The control animals, of which the mean BBB score was 8.1 B 0.7 at 12 weeks after the vehicle transplantation, could not support their weight on Watanabe/Nakamura/Iwanami/Fujita/ Kanemura/Toyama/Okano both their hindlimbs. In contrast, the rats in the spinalcord-and forebrain-derived NSPC transplantation groups showed better motor function recovery, and their BBB scores reached a statistically significant difference at 4 weeks after transplantation, when compared to the control group. Eventually, the spinal-cord-and forebrainderived NSPC transplantation groups obtained BBB scores of 11.2 B 0.9 and 12.0 B 0.5, respectively, at 12 weeks after transplantation. No significant difference in the BBB scores of the spinal-cord-and forebrain-derived NSPC transplantation groups was seen. An inclined plane test was also performed in each animal once a week until 12 weeks after the transplantation or treatment (fig.  5B ). The preoperative mean values of the maximum angle of the inclined plane were about 81.8 B 0.75°. One day after the injury, the mean maximum angle decreased to 24.5 B 0.34°. Nine days after the injury (before transplantation), the mean maximum angle increased to 30.9 B 0.76°. The mean maximum angle of the control group was 45.0 B 1.1° at 12 weeks after the treatment. Compared to the control group, both NSPC transplantation groups showed a better functional recovery, with their mean maximum angle reaching a statistically significant difference at 8 weeks after transplantation. Eventually, the mean maximum angles of the spinal-cord-and forebrain-derived NSPC transplantation groups reached 50.0 B 2.2 and 51.0 B 1.9°, respectively. No significant difference in the mean maximum angle was seen between the two NSPC transplantation groups throughout the experiment.
Discussion
Fetal Spinal-Cord-and Forebrain-Derived NSPCs Have Different in vitro Characteristics
Recent studies report the isolation and/or expansion of NSPCs from adult [Gritti et al., 1996; Johe et al., 1996; Palmer et al., 1997; Weiss et al., 1996] and embryonic [Davis and Temple, 1994; Deloulme et al., 1991; Johe et al., 1996; Kalyani et al., 1997; Richards et al., 1992] rodent CNS tissues, as well as fetal [Brustle et al., 1998; Flax et al., 1998; Kanemura et al., 2002; Keyoung et al., 2001; Svendsen et al., 1996 Svendsen et al., , 1999 and adult [Kukekov et al., 1999; Roy et al., 2000] human CNS tissues. These NSPCs can be grown in vitro in the presence of EGF, FGF-2 or both as a population of continuously dividing cells (with the doubling time of 22.6 B 3.1 h for forebrainderived NSPCs, and 36.8 B 6.4 h for spinal-cord-derived NSPCs [K.W., Y.F. and H.O., unpubl. results]) that retain their multipotential differentiation ability [Murphy et al., 1990; Palmer et al., 1995; Weiss, 1992, 1996; Richards et al., 1992; Ray and Gage, 1994; Sensenbrenner et al., 1994; Svendsen et al., 1996 Svendsen et al., , 1999 Vescovi et al., 1993] . In the present study, we demonstrated that both spinal-cord-and forebrain-derived neurospheres can give rise to neurons, astrocytes and oligodendrocytes in vitro ( fig. 1A-C) . Interestingly, forebrainderived NSPCs differentiated into more neurons and fewer oligodendrocytes, compared to spinal-cord-derived NSPCs, in the in vitro differentiation assay ( fig. 1M ). These findings indicate that the intrinsic potential of spinal cord-and forebrain-derived NSPCs to differentiate into neuronal and glial lineages differs.
Comparison of Spinal-Cord-and Forebrain-Derived NSPC Phenotypes of Injured Spinal Cord after Transplantation
Previous studies have demonstrated that transplanted forebrain-derived NSPCs can survive, migrate and differentiate at various sites in the brain, including the striatum [Martinez-Serrano and Björklund, 1996] , hippocampus [Fricker et al., 1999; Gage et al., 1995] , ventricles [Brustle et al, 1997; Yandava et al., 1999] , subventricular zone [Fricker et al., 1999] , olfactory bulb [Suhonen et al., 1996] , cerebellum [Suhonen et al., 1996] , retina [Nishida et al., 2000] and spinal cord [Cao et al., 2001; Wu et al., 2001] . Wu et al. [2001] demonstrated that hippocampusderived NSPCs transplanted into the injured spinal cords of young rats migrated and differentiated into mainly GFAP-positive cells, a few ß3-tubulin-positive cells and no APC-positive cells. Cao et al. [2001] also demonstrated that adult subventricular-zone-derived NSPCs grafted into the intact or injured spinal cord of adult rats survived, migrated and differentiated into astrocytes and oligodendrocytes, but not into neurons. In the present study, however, we showed that both spinal-cord-and forebrain-derived NSPCs survived, migrated and differentiated into neurons, astrocytes and oligodendrocytes in response to the microenvironment within the injured spinal cord after transplantation ( fig. 3A-F) . Some possible explanations for these differences are as follows. First, we transplanted NSPCs into the injured spinal cord as neurospheres, instead of single cells. Neurosphere transplantation is more effective for cell survival and neurogenesis than a single cell suspension because the cell-cell contacts and autocrine and/or paracrine factors within the neurospheres play an important role in their survival and neuronal differentiation [Taupin et al., 2000] . Second, we transplanted NSPCs into the spinal cord 9 days after inju-ry; this enabled the neuronal differentiation of the grafted NSPCs to occur because the microenvironment within the injured spinal cord was no longer in the acute inflammatory phase [Okano, 2002a, b; Okano et al., 2003; Nakamura et al., 2003; Okada et al., 2004] . This notion is supported by a recent study in which NSPCs grafted immediately after spinal cord injury differentiated into only astro-and oligodendroglial lineages [Vroemen et al., 2003] .
The quantitative analysis revealed that forebrain-derived NSPCs differentiated into more neurons and fewer oligodendrocytes, compared to spinal-cord-derived NSPCs, after transplantation ( fig. 3J ). Interestingly, this in vivo differentiation pattern was similar to that seen in vitro. Most of the Hu-positive cells that differentiated from the grafted NSPCs did not express any of the more mature neuronal markers and were therefore classified as immature neurons. Notably, however, some of the cells that had originated from the forebrain-derived or spinal cord-derived NSPCs and were located in the host white matter contained neurotransmitters, like GABA, glutamate or glycine, similar to cells in normal spinal cord ( fig. 3G-I ). These neurons were located exclusively at the graft-host border, within the white matter. Much lower numbers of glycinergic neurons are known to be present in the forebrain of normal mammals [Aprison, 1990; Cortés and Palacios, 1990; Probst et al., 1986] compared with GABA neurons which are the major inhibitory neurons in the brain. Furthermore, our present results clearly showed that forebrain-derived NSPCs never differentiated into glycinergic neurons in vitro at least 5 days after the induction of differentiation, although the GABA-or glutamatecontaining neurons were identified in the same condition. However, we cannot exclude the possibility that glycinergic neurons might emerge upon longer periods of in vitro differentiation. Taken together, these findings indicate that environmental cues within the injured spinal cord (at 9 days after the injury and during the later stages of recovery) had induced the forebrain-derived NSPCs to differentiate into neurons with spinal-cord-type neurotransmitter phenotypes. Consistent with the present observations, previous reports have shown that long-term in vitro propagated human NSPCs demonstrate site-specific differentiation in the adult brain upon transplantation, without losing their capacity to respond to the extracellular cues that are present in the adult CNS [Fricker et al., 1999] . Catapano et al. [1999] also reported that neural precursors transplanted into multiple positions of the striatum differentiated in response to microenvironmental signals in the transplanted site.
Transplantation of Spinal-Cord-and ForebrainDerived NSPCs Improved Motor Function Recovery
The behavioral analysis revealed that the transplantation of both spinal-cord-and forebrain-derived NSPCs improved the functional recovery of rats with injured spinal cords. One possible explanation for the functional improvement in the rats that underwent transplantations is that oligodendrocytes derived from the grafted cells remyelinated fibers that had been demyelinated as a result of the injury [Crowe et al., 1997] , thereby restoring connectivity. We showed that most of the grafted NSPCs, which migrated into the white matter, were APC-positive oligodendrocytes and that these cells were closely associated with RT97-positive neurofilaments at the surrounding white matter of the lesion site ( fig. 4C, D) . These donor-derived oligodendrocytes may have remyelinated the demyelinated axons, preventing the delayed functional loss caused by demyelination. Another possible explanation is that donor-derived neurons formed new synapses with the host neurons and might have relayed the neuronal circuits that had been disrupted by the injury, as proposed by Ogawa et al. [2002] and Okano et al. [2003] . Alternatively, synapse formation by donor-derived inhibitory neurons (glycinergic neurons and GABAergic neurons) could be important for motor coordination within the spinal neuronal network as well as the suppression of injury-induced spasticity. Furthermore, the majority of the cells that differentiated from either spinal-cord-or forebrain-derived NSPCs in the present study were astrocytes. These astrocytes may have played active roles in the generation of neuronal cells and the axonal regeneration of host neuronal axons. Notably, fetal brain-derived astrocytes have been shown to regulate the precise growth of neuronal axons [Garcia-Abreu et al., 2000] and to promote the physiological maturation of neuronal cells [Blondel et al., 2000] . In the present study, we could demonstrate that some of the graft-derived cells had distributed in the subpial matter ( fig. 2G ), while other cells had migrated radially from the center of the spinal cord to the white matter ( fig. 2D, E) . These cells may have characteristics that are similar to so-called 'radial glia'. Based on these observations, an attractive model for the improvement in motor function seen in the present study may be that the donor-derived astrocytes exhibited characteristics similar to those of fetal CNS-derived astrocytes, rather than the reactive astrocytes induced after CNS injury, since fetal CNS-derived and in vitro expanded NSPCs were used as the donor cells in the present study. Alternatively, the trophic effects (which indicate that functional improvement may not be dependent on transplanted cells Watanabe/Nakamura/Iwanami/Fujita/ Kanemura/Toyama/Okano becoming functional neurons and making the right connections, but rather transplanted cells are 'trophic factor' factories) might also be effective for the survival and differentiation of the host cells in the injured spinal cord leading to functional recovery.
In the present study, we have used female rats. Many investigators have used female rats for this type of research [McDonald et al., 1999; Ogawa et al., 2002; Cao et al., 2001; Widenfalk et al., 2003; Vroemen et al., 2003] , possibly for the following reasons. First, male rats gain up to 400-500 g body weight by 12 weeks after surgery, making the behavioral assessment difficult, as the function of the hindlimbs, which are the weight-bearing limbs, is compromised by the surgery. The second reason is the bladder problem that arises as a consequence of spinal cord injury. Male rats have longer urethras than females. Therefore, it is harder to induce manual urination in the males after the spinal cord injury. Consequently, postoperative survival rates are lower in the males. It should be noted that estrogen has neuroprotective effects in the CNS following trauma [Roof and Hall, 2000] or ischemia [Dubal et al., 1999] . The estrous cycle of our female rats was not monitored. Therefore, the effects of estrus on the outcome of the neurological tests cannot be ruled out.
Conclusions
Fetal forebrain-derived NSPCs, which have a higher proliferative ability than fetal spinal-cord-derived NSPCs in vitro, can generate astrocytes, oligodendrocytes and neurons that have neurotransmitter phenotypes similar to spinal cord neurons after transplantation into injured spinal cord. Thus, fetal forebrain-derived NSPCs may be useful as a future therapeutic reagent for spinal cord injuries.
